Nefiracetam

Overview

Nefiracetam is a cognition-enhancing agent. Nefiracetam is an activator of nAChR , N-methyl-D-aspartate receptor ( NMDAR ), mGluR5 , PKC , gamma-aminobutyric acid ( GABA ), and N/L-type Ca 2+ channels. Nefiracetam promotes neuroplasticity and enhances neuroprotection. Nefiracetam can be used in Alzheimer's disease, epilepsy, and cerebral ischemia research.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Depression | Products > Disease Areas > Pain | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Parkinson's Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > TGF-beta/Smad | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > PKC | Products > Signaling Pathways > GABA Receptor | Products > Signaling Pathways > Calcium Channel | Products > Signaling Pathways > nAChR | Products > Signaling Pathways > iGluR | Products > Signaling Pathways > mGluR

Product Information

• Catalog No.: HY-B0340
• CAS No.: 77191-36-7
• Molecular Formula: C14H18N2O2
• Molecular Weight: 246.30
• Purity: 99.87%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (10.15 mM); Clear solution
• Availability: In-stock

Source

Original product source